Results 281 to 290 of about 326,995 (379)

Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras

, 2003
Christian Junghanß, Alessandra Takatu, Marie-Térèse Little, Jan Maciej Zaucha, Eustacia Zellmer, Murad Y. Yunusov, George Sale, George E. Georges, Rainer Storb   +8 more
openalex   +1 more source

37: Cytotoxic T Lymphocytes (CTL) Specific for Multiple Viruses Can Be Generated From Umbilical Cord Blood for Adoptive Immunotherapy [PDF]

, 2008
Catherine M. Bollard, Mariam Khalil, Ann M. Leen, Conrad Russell Y. Cruz, William K. Decker, Gianpietro Dotti, Jeffrey J. Molldrem, Cliona M. Rooney, Helen E. Heslop, Elizabeth J. Shpall   +9 more
openalex   +1 more source

Role of memory T cell subsets for adoptive immunotherapy.

Seminars in Immunology, 2016
D. Busch, Simon P. Fräßle, D. Sommermeyer, V. R. Buchholz, S. Riddell   +4 more
semanticscholar   +1 more source

Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. [PDF]

J Immunother Cancer
Razmara AM, Farley LE, Harris RM, Judge SJ, Lammers M, Iranpur KR, Johnson EG, Dunai C, Murphy WJ, Brown CT, Rebhun RB, Kent MS, Canter RJ.   +12 more
europepmc   +1 more source

172Ex vivo engineering of previously thawed and cryopreserved umbilical cord blood (UCB) with interleukin (IL)-2, IL-7, IL-12 and anti-CD3 for expansion of cytotoxic T lymphocytes (CTL): Promising strategy for adoptive cellular immunotherapy (ACI) post UCB transplantation (T)

, 2003
Mitchell S. Cairo, Janet Ayello, C. van de Ven   +2 more
openalex   +1 more source

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy [PDF]

, 2008
Christian S. Hinrichs, Rosanne Spolski, Chrystal M. Paulos, Luca Gattinoni, Keith Kerstann, Douglas C. Palmer, Christopher A. Klebanoff, Steven A. Rosenberg, Warren J. Leonard, Nicholas P. Restifo   +9 more
openalex   +1 more source

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 Antagonism

Arthritis &Rheumatology, Accepted Article.
Background JAK inhibition (JAKi) is effective in seronegative spondyloarthropathy (SpA) spectrum disorders, but TYK2 inhibition failed in SpA spectrum ulcerative colitis, and tofacitinib showed minimal benefit in Crohn's Disease, which highlights the complex role for JAK‐STAT signaling in different inflammatory processes. In this study, we investigated
Sami Giryes, Chi Wong, Charlie Bridgewood, Mark Harland, Ala Altaie, Nicole McDermott, Kerem Abacar, Abhay Rao, Almas Khan, Tristan McMillan, Peter Loughenbery, Robert Dunsmuir, Vishal Borse, Tom Macleod, Dennis McGonagle   +14 more
wiley   +1 more source

Chimeric antigen receptor adoptive immunotherapy in central nervous system tumors: state of the art on clinical trials, challenges, and emerging strategies to addressing them. [PDF]

Curr Opin Oncol
Del Baldo G, Carai A, Mastronuzzi A.
europepmc   +1 more source

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells. [PDF]

Neurology, 2022
Karschnia P, Rejeski K, Winkelmann M, Schöberl F, Bücklein VL, Blumenberg V, Schmidt C, Blobner J, von Bergwelt-Baildon M, Tonn JC, Kunz WG, Subklewe M, von Baumgarten L.   +12 more
europepmc   +1 more source

Post-transplant adoptive T-cell immunotherapy [PDF]

, 2008
Nicole A. Aqui, Carl H. June
openalex   +1 more source